“…With the advantages of sensitivity, specificity, rapidity, simplicity and cost-effectiveness, immunochemical methods, especially enzyme-linked immunosorbent assay (ELISA), is becoming more and more useful for screening benzodiazepines in toxicological and clinical samples. Many immunoassay methods for benzodiazepines have been developed in the past two decades (Barrett et al, 1999;Borrey et al, 2002;Elian, 2003;Huang & Moody, 1995;Kemp, Sneed, Kupiec, & Spiehler, 2002;Li et al, 2008;Meatherall & Fraser, 1998;Miller, Wylie, & Oliver, 2006;Peng et al, 2008a,b; . Various authors (Elian, 2003;Huang & Moody, 1995) have tested commercial immunoassays for their specificity against benzodiazepines, benzodiazepine metabolites, clonazepam and 7-aminoclonazepam, however, these assay either did not detect all of the compounds or had low cross-reactivities (CRs) with the compounds (Liu & Xu, 2007;Wang, Xu, & Peng, 2006;Xu et al, 2006a,b,c,d).…”